Vascular Closure Devices – Market Insights – Global

The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedural volumes and innovations in products and techniques. The shift toward radial access will continue to impact choice of device use.

This Medtech 360 Report provides comprehensive data and analysis on the state of the global market for VCDs from 2019 through 2032.

The global VCD market is driven by procedural trends in many endovascular market segments.

Which trends are impacting endovascular procedure volumes? 

How did the COVID-19 pandemic affect these procedures?

Which types of procedures are seeing the strongest growth, and how is this impacting adoption of various VCDs?

The pace of adoption of radial access varies between countries.

How have guidelines adapted to the increasing volume of clinical data showing the benefits of radial access?

In which countries are physicians more likely to adopt the radial approach for endovascular procedures?

How will the continued shift to radial access from femoral access affect the VCD market?

Clinical data plays a significant role in vascular closure device choice.

Which devices are benefiting from favorable clinical data?

How will the accumulation of real-world experience following product launches affect the uptake of new VCDs?

For which devices are strong clinical evidence currently lacking?

Devices soon to enter or in development across the global market will contribute to continued adoption of vascular closure over manual compression.

What areas of improvements are the innovations in the vascular space aiming for?

What has been the initial adoption of the recently launched VCDs across the global markets?